SHH-mediated GLI1 activity lead to the transcriptional activation of the cysteine-rich angiogenic inducer 61 (CYR61); silencing CYR61 resulted in reduced tumor vasculature of SHH-driven xenografts [92]. The gene discussed is SHH; the disease is neoplasm.